Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

C4 Therapeutics (CCCC) Leases (2019 - 2025)

C4 Therapeutics (CCCC) has 7 years of Leases data on record, last reported at $40.5 million in Q4 2025.

  • For Q4 2025, Leases fell 29.55% year-over-year to $40.5 million; the TTM value through Dec 2025 reached $40.5 million, down 29.55%, while the annual FY2025 figure was $40.5 million, 29.55% down from the prior year.
  • Leases reached $40.5 million in Q4 2025 per CCCC's latest filing, down from $42.0 million in the prior quarter.
  • Across five years, Leases topped out at $74.8 million in Q1 2022 and bottomed at $12.2 million in Q3 2021.
  • Average Leases over 5 years is $52.8 million, with a median of $60.0 million recorded in 2024.
  • Peak YoY movement for Leases: skyrocketed 484.68% in 2022, then decreased 29.55% in 2025.
  • A 5-year view of Leases shows it stood at $31.9 million in 2021, then soared by 119.49% to $70.1 million in 2022, then fell by 8.79% to $64.0 million in 2023, then dropped by 10.04% to $57.5 million in 2024, then decreased by 29.55% to $40.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $40.5 million in Q4 2025, $42.0 million in Q3 2025, and $54.2 million in Q2 2025.